Coexpression of epidermal growth factor receptor and TGF-α and survival in upper aerodigestive tract cancer

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 283-288

  Issing, Wolfgang J ^a   Liebich, Christoph ^a   Wustrow, Thomas P U ^a   Ullrich, Axel ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Autocrine loop; EGFR; Head and neck cancer; Oncogenes; TGF

Indexed keywords

CELL SURFACE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HEAD CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MALE; MOLECULAR BIOLOGY; NECK CANCER; PRIORITY JOURNAL; PROGNOSIS; TUMOR CLASSIFICATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKERS, BIOLOGICAL;

EID: 0029963984     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Vogelstein B, and Kinzler KW: The multistep nature of cancer: TIG, 4: 138-141, 1993.
2. Kamb A, Nelleke AG, Weaver-Feldhaus J, Liu Q , Harshman K, Tavtigan SV, Stockert E, Day III RS, Johnson BE and Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264: 436-440, 1994.
3. King CR, Kraus MH and Aaronson SA. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229: 974-976, 1985.
4. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF: Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 244: 707-712, 1989.
5. Lacroix H, Iglehart JD, Skinner MA and Kraus MH: Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene 4 145-151, 1989.
6. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullric A, Schlessinger J and Waterfield MD: Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature (Lond.), 307: 521-527, 1984.
7. Ullrich A, Coussens L, Hayflick JS, Bull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD and Seeburg PH: Human epidermal growth factor receptor c-DNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309: 418-425, 1984.
8. Todaro GJ and De Larco JE: Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells. Nature, 264: 26-31, 1976.
9. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS and Berger WH: Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47: 707-712, 1987
10. Sporn MB and Todaro GJ: Autocrine secretion and malignant transformation of cells. N Engl J Med 303: 878-880, 1980.
11. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA and Di Fiore PP: Autocrine interaction between TGF-α and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4: 831-838, 1989.
12. Issing WJ, Wustrow TPU and Heppt WJ: Oncogenes related to head and neck cancer. Anticancer Res 13: 2541-2551, 1993.
13. Ozawa S, Masakazu U, Ando N, Abe O, Hirai M and Shimizu N. Stimulation by EGF of the growth of EGF receptor-hyperproducing tumor cells in athymic mice Int J Cancer 40: 706-710, 1987.
14. Hendler F, Shum SA, Nanu L and Ozanne B: Overexpression of EGF receptor in squamous tumors is associated with poor survival. J Cell Biochem S12C: 105, 1988.
15. Bauknecht T: The evidence and evaluation of epidermal growth factor receptors and EGF-like factors as prognostic agent in ovarian carcinoma. J Cell Biochem S10C: 161, 1986.
16. Slaughter DP, Southwick HW and Smejkal W: "Field cancerization" in oral stratified squamous epithelium, clinical implications of multicentric origin. Cancer (Phila.) 5: 963-968, 1953
17. Dassonville O, Formento JL, Francoual M, Ramaioli A, Santini J, Schneider M, Demard F, and Milano G: Expression of epidermal growth factor receptor and survival in upper aerodigestiv tract cancer. J Clin Oncol 11: 1873-1878, 1993.
18. Kris R, Lax I, Gulliek W, Waterfield MD, Ullrich A, Fridkin M and Schlessinger J: Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF-R and v-erbB protein. Cell 40: 619-625, 1985.
19. Sporn MB and Roberts AB. Autocrine growth factors and cancer. Nature (Lond.), 313: 747-751, 1985.
20. Finzi E, Fleming T, Segatto O, Pennington CY, Bringman TS, Derynck R and Aaronson SA: The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH/3T3 cells. Proc Natl Acad Sci USA 84: 3733-3737, 1987.
21. Rosenthal A, Lindquist PB, Bringman TS, Goeddel DV and Derynck R: Expression in rat fibroblasts of a human transforming growth factor α cDNA results in transformation. Cell 46: 301-309, 1986.
22. Watkins LF and Levine AE: Differential role of transforming growth factor α in two human colon-carcinoma cell lines. Int J Cancer, 47: 455-460, 1991.
23. Karnes WE, Walsh JH, Wux SV, Kim RS, Martin MG, Wong HC, Mendelsohn J, Park J-G and Cuttitta F: Autonomous proliferation of colon cancer cells that coexpress transforming growth factor α and its receptor. Gastroenterology 102: 474-485, 1992.
24. Gorgoulis V, Aninos D, Priftis C, Evagelopoulou C, Karameris A, Kanavaros P, and Spandidos DA: Expression of the epidermal growth factor, transforming growth factor α and epidermal growth factor receptor in thyroid tumors. In vivo 6: 291-296, 1992.
25. Iihara K, Shiozaki H, Tahara H, Kobayashi K, Inoue M, Tamura S, Miyata M, Oka H, Doki Y, and Mori T: Prognostic significance of transforming growth factor α in human esophageal carcinoma. Cancer 71: 2902-2909, 1993.
26. Yano H, Shiozaki H, Kobayashi K, Yano T, Tahara H, Tamura S and Mori T: Immunohistologic detection of the epidermal growth factor receptor in human esophageal squamous cell carcinoma. Cancer 67: 91-98, 1991.
27. Mukaiada H, Toi M, Hirai T, Yamashita Y, and Toge T: Clinical significance of the expression of the epidermal growth factor and its receptor in esphageal cancer. Cancer 68: 142-148, 1991.
28. Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O and Demard F: Characterization, quantification and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 13: 132-139, 1991
29. Miyaguchi M, Olofsson J and Hellquist HB: Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clin Otolaryngol 16. 466-469, 1991.
30. Shirasuna K, Hayashido Y, Sugiyama M, Yoshioka H and Matsuya T: Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy. Virchows Arch A Pathol Anat Histopathol 418: 349-353, 1991.
31. Di Marco E, Albanese E, Benso S, Beatrice F, Cancedda R and Toma S: Expression of epidermal growth factor receptor and transforming growth factor α in human larynx carcinoma. Cancer Letters 65: 189-199, 1992.
32. Christensen ME, Therkildsen MH, Poulsen SS, and Bretlau P: Transforming growth factor alpha and epidermal growth factor in laryngeal carcinomas demonstrated by immunohistochemistry. Act Otolaryngol (Stockh.) 113: 563-567, 1993.
33. Grandis JR and Tweardy DJ: Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53: 3579-3584, 1993.
34. Yonemura Y, Takamura H, Ninomiya I, Fushida S, Tsugawa K, Kaji M, Nakai Y, Ohoyama S, Yamaguchi A and Miyazaki I: Interrelationship between transforming growth factor α and epidermal growth factor receptor in advanced gastric cancer. Oncology 49: 157-161, 1992.